Enteralok® Enteral Syringe is launched in response to NPSA guidelines
Added: (Thu Feb 12 2009)
Pressbox (Press Release) -
A new range of enteral syringes has been launched by Sheffield based InterVene® Ltd.
In recent years, numerous deaths have occurred by administering enteral medication via intravenous (IV) lines. The enteral syringe which was designed in UK, has been produced in response to National Patient Safety Agency (NPSA) guidelines aimed at preventing maladministration of enteral medication via IV routes.
The syringe employs a ‘reverse luer’ or ‘female luer’ tip which cannot be interchanged with a conventional IV syringe. A purple plunger immediately identifies the syringe as an enteral device and the words ‘Enteral / Oral’ are clearly displayed on the barrel.
The name Enteralok® is derived from the Enteral function of the syringe and the type of female Luer Lock tip engineered into the device in order to comply with regulations. In addition, it is OK to use this syringe for Enteral feeding, hence Enteral-ok…Enteralok®.
The syringe will be available from 1st March via NHS Supply Chain or direct form InterVene and comes in 1ml, 2.5ml, 5ml, 10ml and 60ml sizes. An additional 20ml syringe is now also in production.
InterVene Ltd was formed specifically to meet the growing needs for innovative safety products. Matt Root, Managing Director, said: “All our products have been designed with safety in mind, either for the healthcare professional or the patient. Safety is no accident and that is why we believe so strongly in a range of products that encourages best practice and stops the spread of infections and the incidence of maladministration.”
One of InterVene’s next projects is to devise a system that prevents maladministration of medication via intrathecal injections.
For more information about InterVene visit http://www.ivltd.co.uk/.